A detailed history of American International Group, Inc. transactions in Savara Inc stock. As of the latest transaction made, American International Group, Inc. holds 44,520 shares of SVRA stock, worth $191,436. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,520
Previous 44,903 0.85%
Holding current value
$191,436
Previous $211,000 4.74%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$4.19 - $5.59 $1,604 - $2,140
-383 Reduced 0.85%
44,520 $221,000
Q4 2023

Feb 13, 2024

SELL
$3.18 - $4.9 $575 - $886
-181 Reduced 0.4%
44,903 $211,000
Q3 2023

Nov 13, 2023

BUY
$2.97 - $3.88 $24,909 - $32,541
8,387 Added 22.85%
45,084 $170,000
Q2 2023

Aug 04, 2023

BUY
$1.69 - $3.24 $62,017 - $118,898
36,697 New
36,697 $117,000
Q2 2021

Aug 13, 2021

SELL
$1.51 - $2.29 $42,376 - $64,266
-28,064 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$1.17 - $2.33 $87 - $174
75 Added 0.27%
28,064 $58,000
Q4 2020

Feb 12, 2021

SELL
$1.0 - $1.47 $803 - $1,180
-803 Reduced 2.79%
27,989 $32,000
Q3 2020

Nov 04, 2020

BUY
$1.09 - $2.21 $438 - $888
402 Added 1.42%
28,792 $31,000
Q2 2020

Aug 12, 2020

BUY
$1.8 - $3.05 $14,133 - $23,948
7,852 Added 38.23%
28,390 $71,000
Q1 2020

May 04, 2020

SELL
$1.91 - $4.08 $2,267 - $4,842
-1,187 Reduced 5.46%
20,538 $44,000
Q4 2019

Feb 05, 2020

SELL
$0.71 - $4.91 $129 - $893
-182 Reduced 0.83%
21,725 $97,000
Q3 2019

Nov 08, 2019

BUY
$2.16 - $3.2 $3,689 - $5,465
1,708 Added 8.46%
21,907 $58,000
Q2 2019

Aug 13, 2019

BUY
$2.37 - $11.7 $4,562 - $22,522
1,925 Added 10.53%
20,199 $48,000
Q1 2019

May 06, 2019

SELL
$6.71 - $8.6 $3,972 - $5,091
-592 Reduced 3.14%
18,274 $135,000
Q4 2018

Feb 13, 2019

SELL
$6.27 - $10.92 $909 - $1,583
-145 Reduced 0.76%
18,866 $143,000
Q3 2018

Nov 09, 2018

BUY
$10.49 - $12.87 $28,637 - $35,135
2,730 Added 16.77%
19,011 $212,000
Q2 2018

Aug 08, 2018

BUY
$8.55 - $13.76 $139,202 - $224,026
16,281 New
16,281 $184,000

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $490M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.